Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)
This study has been withdrawn prior to enrollment.
First Posted: March 18, 2011
Last Update Posted: February 20, 2012
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||February 2016|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|